ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement - PR Newswire

/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD ('Lepton"). This is a non-exclusive...

Lepton Pharmaceutical LTD is a biotechnology company developing a proprietary, breakthrough technology (Castling Technology) to substantially improve adaptive cell-mediated immune response (T-cells, … [+2679 chars]

full article...